BELVIQ XR Trademark Information

Trademark by Arena Pharmaceuticals GmbH

Pharmaceutical preparations to treat or prevent obesity; pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; Pharmaceutical preparations for the treatment and prevention of diabetes and metabolic disorders; Pharmaceutical preparations for the promotion of smoking cessation; Pharmaceutical preparations for the treatment and prevention of drug and alcohol abuse

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: BELVIQ XR
Status/Status Date:
REGISTERED
3/22/2016
Estimated Renewal Deadline: March 22, 2022
Serial Number: 86693911
Filing Date: 7/15/2015
Registration Number: 4922297
Registration Date: 3/22/2016
Goods and Services: Pharmaceutical preparations to treat or prevent obesity; pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; Pharmaceutical preparations for the treatment and prevention of diabetes and metabolic disorders; Pharmaceutical preparations for the promotion of smoking cessation; Pharmaceutical preparations for the treatment and prevention of drug and alcohol abuse
Mark Description: The mark consists of the stylized terms "BELVIQ XR." The letter "X" in the term "XR" has four parallelograms stacked above one another under its bottom left side. The four parallelograms fade in color from the first one to the last one. The gray tones are intended to indicate shading only.
Type Of Mark: TradeMark
Published For Opposition Date: 1/5/2016
Last Applicant/Owner:
Arena Pharmaceuticals GmbH
CH-4800 Zofingen
Mark Drawing Code: Drawing/Design + Words
Design Search:
Three or more quadrilaterals (Geometric figures and solids - Quadrilaterals) see more design...
Quadrilaterals that are completely or partially shaded (Geometric figures and solids - Quadrilaterals) see more design...
Register Type: Principal
Disclaimer: ("XR")
Correspondent:
Fross Zelnick Lehrman & Zissu P C
4 TIMES SQUARE, 17TH FLOOR
NEW YORK, NY 10036
Current Status:
REGISTERED
3/22/2016
Correspondent Search:
ALLISON STRICKLAND RICKETTS is a correspondent of BELVIQ XR trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on